20 December 2022
European QP Association announces Changes in Leadership
The European QP Association (EQPA), representing more than 4.200 Qualified Persons (QPs) and professionals in similar functions from across Europe and beyond, has announced changes in its Advisory Board.
Cheryl Chia was invited to join the EQPA Board of Directors, extending the board’s industry side from five to six members. Cheryl has been an independent consultant since 2019, providing advice and acting as QP if necessary to pharmaceutical companies that are developing their organisations in Europe. Cheryl was originally a hospital pharmacist in England and made the switch to Industrial Pharmacist when she moved to the Netherlands in 2002. There she worked for seven years at Organon N.V. in various roles and for ten years at Amgen Europe B.V. in various roles including Production QA, QP and RP and Supply Chain.
Further, the EQPA’s IMP Working Group, representing more than 2.100 Qualified Persons (QPs) and professionals in the Investigational Medicinal Products (IMP) area also announced a change in its group leadership.
After seven very successful years of excellent work, Brenda Van Assche is now winding down her responsibilities in the group. The group has appointed Katrien Himpens as Brenda’s successor with the aim of maintaining the same spread of pharmaceutical company size. Katrien is Director Quality Assurance and Qualified Person JSC at Janssen, Pharmaceutical Companies of Johnson and Johnson. “I would like to extend my heartfelt thanks to Brenda for her outstanding service to the board and her energizing and inspiring contribution to the success of the organization” Dr Susanne Ding expressed her thanks for the long-time leadership colleague. “At the same time, we very much look forward to working with Katrien. With her experience she will definitely be a very valuable addition to our team.”
<< Back to overview
|
